“Computer algorithms to identify drug induced liver injury in electronic medical records” Christine Hunt, MD, MPH Adjunct Associate Professor Department of Medicine, Duke University
“Overcoming an immunological backlash from modern sanitation practices: The return of the intestinal worm ” William Parker, PhD Associate Professor in Surgery Duke University Medical Center Dr. Parker has studied biochemistry and immunology at Duke University since 1993. He is best known for the discovery of the function of the human vermiform appendix (a safe-house for … Read more
“Is it important to improve the Quality of Clinical Practice Guidelines? Evolution of—and lessons from CRC screening guidelines” David Ransohoff, MD Professor of Medicine Department of Medicine, GI Division The University of North Carolina at Chapel Hill
“The Gut Microbiome Regulates Mucosal and Systemic Inflammation in IBD ” Randy Longman, MD PhD Assistant Professor Department of Medicine Division of Gastroenterology and Hepatology Weill Cornell Medical Center Dr. Randy Longman is an Assistant Professor of Medicine at Weill Cornell Medicine and a member of the Jill Roberts Center and Institute for Research in Inflammatory … Read more
“Opportunities for research and clinical partnerships with the Health Sciences Library” Rebecca McCall, MLS Clinical Librarian Health Sciences Library The University of North Carolina at Chapel Hill
“ The epigenetics of T cell fate decisions: If it were always EZ(h2)” William Faubion, MD Professor Departments of Internal Medicine, Immunology and Pediatrics Mayo Medical School Director, Pediatric Inflammatory Bowel Disease Center at the Mayo Clinic Dr. Faubion is the principal investigator of the T32 training grant and Vice-Chair of Research for the adult GI … Read more
“Estrogen, Obesity & Diverticulosis: Work in Progress” Anne Peery, MD, MSCR Assistant Professor of Medicine Department of Medicine, GI Division The University of North Carolina at Chapel Hill
“ Gut microbiota dysbiosis in infection and IBD: from iron to new therapies ” Andre G. Buret, PhD Professor Departments of Biologicals Sciences, Physiology and Pharmacology Associate Vice-President Research University of Calgary Dr. Buret’s research: Similar inflammatory, immunologic, and pathophysiologic events characterize disease processes at mucosal sites such as the intestine and the lung. Critical issues to … Read more
“How to plan an investigator initiated trial” Hans Herfarth, MD, PhD Professor of Medicine Division of Gastroenterology and Hepatology Co-Director, UNC Multidisciplinary Inflammatory Bowel Diseases Center Department of Medicine - GI Division The University of North Carolina at Chapel Hill
“ Does Gastrin Signaling limit the ability of PPIs to prevent Esophageal Cancer? ” Katherine S. Garman, MD, MHS Associate Professor of Medicine Division of Gastroenterology Member of the Molecular and Physiology Institute Duke University Practicing Gastroenterologist at the Durham VA The Garman lab is focused on mechanisms of esophageal repair and the pathogenesis of … Read more